Scientists in the UK have developed a blood test which indicates whether patients will respond to antidepressants, and which type of drug specifically is best suited to them.
At the moment, most medication is prescribed to patients on a trial and error basis in which they are monitored while on the medication to see if it is suitable.
Now, because of this development, doctors can perform a test to see whether patients are suited to their medication without prescribing them first.
A spokesperson from the College of Psychiatrists of Ireland said that they welcome these scientific advances that improve assessment in choosing treatments individually tailored for people with mental illness.
“It is encouraging and right that mental illness is included in these advances,” said Dr John Hillery, referring to scientific research’s ability to move treatment forward.
“Further development in blood assessment and neuroimaging, which enhance individual focused care and enable relief of symptoms and recovery to the life a person wants, are always valued.”
The tests measure two inflammation biomarkers in the blood, shown in previous studies to be linked to a poor response to antidepressants.
It was found that those tested who had high levels of both biomarkers would definitely not respond to common antidepressants. Those whose levels were below a certain number were expected to respond to the commonly prescribed medication.
While the College of Psychiatrists of Ireland say they welcome this news, they also say that Ireland is limited in terms of many of the resources.
“All people with mental illness need access to psychotherapeutic interventions whether or not pharmacological intervention is indicated.
“Access to non-pharmacological treatment in the public service is still limited by resource problems including staff training. The €12 million ring fenced monies recently dispersed could have been used for staff training in this area.”
LISTEN: You Must Be Jokin’ podcast – listen to the latest episode now!
